Freedom Investment Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.2K | Buy |
29,166
+4,560
| +19% | +$5.65K | ﹤0.01% | 725 |
|
|
2025
Q1 | $29K | Sell |
24,606
-24,185
| -50% | -$28.5K | ﹤0.01% | 732 |
|
|
2024
Q4 | $89.3K | Sell |
48,791
-326
| -0.7% | -$597 | 0.01% | 736 |
|
|
2024
Q3 | $83.5K | Sell |
49,117
-11,022
| -18% | -$18.7K | 0.01% | 742 |
|
|
2024
Q2 | $82.4K | Buy |
60,139
+44,700
| +290% | +$61.2K | 0.01% | 749 |
|
|
2024
Q1 | $57.9K | Buy |
15,439
+4,947
| +47% | +$18.6K | ﹤0.01% | 772 |
|
|
2023
Q4 | $103K | Sell |
10,492
-1,085
| -9% | -$10.6K | 0.01% | 727 |
|
|
2023
Q3 | $96.7K | Sell |
11,577
-2,519
| -18% | -$21K | 0.01% | 650 |
|
|
2023
Q2 | $187K | Buy |
14,096
+2,304
| +20% | +$30.6K | 0.02% | 657 |
|
|
2023
Q1 | $137K | Sell |
11,792
-709
| -6% | -$8.21K | 0.02% | 671 |
|
|
2022
Q4 | $102K | Sell |
12,501
-405
| -3% | -$3.31K | 0.01% | 685 |
|
|
2022
Q3 | $74.9K | Buy |
+12,906
| New | +$74.9K | 0.01% | 698 |
|